Driven by innovation, Kexing Biopharm has made ongoing biopharmaceutical research projects well balanced in term, serial in topic, and progressive in content. Since 2019, Kexing Biopharm has been focused on major biopharmaceutical business with advantageous technology experience, adopted a product strategy combining exploration of advantageous technology and expansion of frontier biotechnology, and made short-, medium- and long-term plans for product lines. In the further stage, Kexing Biopharm will step up investment in biopharmaceutical R&D and innovation.

With over 20 years of accumulation in the field of biologicals, Kexing Biopharm has established a relatively complete system of pharmaceutical R&D, covering pharmaceutical innovation capabilities from pharmaceutical discovery, pharmaceutical research, preclinical research and clinical research to industrialized production, and Kexing Biopharm has developed platforms for core technologies including recombinant protein secretion and expression technology, recombinant protein pharmaceutical industrialization technology, PEGylated recombinant protein technology, micro-ecological product R&D and industrialization technology, etc.